GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Gushengtang Holdings Ltd (HKSE:02273) » Definitions » Peter Lynch Fair Value

Gushengtang Holdings (HKSE:02273) Peter Lynch Fair Value : N/A (As of Dec. 11, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Gushengtang Holdings Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for Gushengtang Holdings's Peter Lynch Fair Value or its related term are showing as below:



HKSE:02273's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.435
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Gushengtang Holdings Peter Lynch Fair Value Historical Data

The historical data trend for Gushengtang Holdings's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gushengtang Holdings Peter Lynch Fair Value Chart

Gushengtang Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
Get a 7-Day Free Trial - - - - -

Gushengtang Holdings Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Gushengtang Holdings's Peter Lynch Fair Value

For the Medical Care Facilities subindustry, Gushengtang Holdings's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gushengtang Holdings's Price-to-Peter-Lynch-Fair-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Gushengtang Holdings's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Gushengtang Holdings's Price-to-Peter-Lynch-Fair-Value falls into.



Gushengtang Holdings Peter Lynch Fair Value Calculation

Gushengtang Holdings's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* N/A *1.108
=N/A

For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gushengtang Holdings's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was HK$1.11.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Gushengtang Holdings  (HKSE:02273) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 0 instead of 15 in this case.

Gushengtang Holdings's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=34.55/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gushengtang Holdings Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Gushengtang Holdings's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Gushengtang Holdings Business Description

Traded in Other Exchanges
Address
No. 419, Qingsha Road, Room 005, Dongchong Town, Nansha District, Guangzhou, CHN
Gushengtang Holdings Ltd is a traditional Chinese medicine (TCM) company. Through offline medical institutions and online healthcare platforms, it provides customers with a comprehensive range of TCM healthcare services and products to address diverse medical and healthcare management needs. As all of the Group's revenue is derived from the PRC.
Executives
Tu Zhiliang 2501 Other
Wumianshan Ltd. 2201 Interest of corporation controlled by you
Frandor Limited
Tu Family Holdings Limited
Trident Trust Company (singapore) Pte. Limited
Dream True Limited
Action Thrive Group Limited 2101 Beneficial owner
Fmr Llc 2201 Interest of corporation controlled by you
Eight Roads Holdings Limited 2201 Interest of corporation controlled by you
Fil Limited 2201 Interest of corporation controlled by you
Eight Roads Shareholdings Limited 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Johnson Iv Edward C. 2301 Trustee
Johnson Abigail P. 2301 Trustee

Gushengtang Holdings Headlines

No Headlines